Vijaya Diagnostic Centre
1,025.25
+5.55(+0.54%)
Market Cap₹10,474.90 Cr
PE Ratio69.25
Company Performance:
1D+0.54%
1M+2.55%
6M+0.69%
1Y+6.14%
5Y+65.34%
View Company Insightsright
More news about Vijaya Diagnostic Centre
29Sept 25
NCLT Hyderabad Reserves Order on Vijaya Diagnostic-Medinova Merger
The National Company Law Tribunal (NCLT) in Hyderabad has reserved its order on the proposed merger between Vijaya Diagnostic Centre Limited and Medinova Diagnostic Services Limited. The merger, with an appointed date of April 1, 2024, is based on a going concern basis under Sections 230 to 232 of the Companies Act, 2013. Vijaya Diagnostic Centre has reported that the attendance-cum-order sheet recording the 'Orders Reserved' status is available on the NCLT website. The company awaits the certified true copy of the order to submit to stock exchanges.
02Aug 25
Vijaya Diagnostic Centre Reports 20.4% Revenue Growth in Q1
Vijaya Diagnostic Centre reported consolidated revenue of Rs. 188.00 crores for Q1, a 20.4% year-on-year growth. The company saw a 17% increase in test volume and 14% rise in patient footfall. EBITDA margin was 39.1% and PAT margin 20.4%. The core Hyderabad market returned to double-digit growth. Five new hubs and one spoke were commissioned across Pune, Bangalore, and West Bengal. The company maintains a strong financial position with a cash balance of Rs. 270.00 crores. Future plans include opening 10 hubs in the current financial year with a CAPEX of Rs. 150.00-155.00 crores for new centers.
28Jul 25
Vijaya Diagnostic Centre Announces Robust Q1 Results and Ambitious Expansion Plans
Vijaya Diagnostic Centre reported impressive Q1 results with 20.4% revenue growth to Rs 1,880.50 crore, 20.1% EBITDA growth to Rs 735.30 crore, and 22.3% PAT growth to Rs 383.40 crore. The company performed 3.94 million tests, a 16.7% increase, with 1.10 million footfalls. Expansion plans include launching 3 new hubs in Q2 and 2 more in West Bengal later this fiscal year. The company aims to achieve break-even across all centers within 12 months, with one Bengaluru hub progressing faster than expected.
28Jul 25
Vijaya Diagnostic Centre Reports Robust Q1 FY26 Performance with 20.5% Revenue Growth
Vijaya Diagnostic Centre announced strong Q1 FY26 results with revenue increasing 20.5% to ₹188.05 crore. Net profit rose 23.1% to ₹38.59 crore, while EBITDA grew to ₹73.50 crore with a margin of 39.10%. The company granted 2,500 ESOPs, appointed a new Secretarial Auditor, and is progressing with a proposed merger with its subsidiary, Medinova Diagnostic Services Limited.
08Jul 25
Vijaya Diagnostic Centre Ltd. Sees Rs. 23.13 Crore Block Trade on NSE
A significant block trade of 230,405 shares of Vijaya Diagnostic Centre Ltd. was executed on the National Stock Exchange (NSE). The transaction was valued at Rs. 23.13 crore, with each share priced at Rs. 1,004.00. This large trade indicates potential shifts in ownership or strategic moves by major shareholders, although the identities of the buyer and seller remain undisclosed. Such transactions can influence market sentiment and the stock's trading pattern in the short term.
12May 25
Vijaya Diagnostic Centre Reports Q4 Growth in EBITDA and Net Profit, Declares Dividend
Vijaya Diagnostic Centre's Q4 results show significant growth across key financial metrics. Revenue increased by 26.05% to ₹173.70 crore, EBITDA rose by 29.60% to ₹71.80 crore, and net profit grew by 35.77% to ₹35.30 crore year-over-year. The company's EBITDA margin improved to 41.34%, and it declared a dividend of ₹2.00 per share. Operating profit reached ₹67.10 crore with a margin of 39.73%, indicating strong core operational performance.
Vijaya Diagnostic Centre
1,025.25
+5.55
(+0.54%)
1 Year Returns:+6.14%
Industry Peers
Dr. Lal Path Labs
3,153.70
(-3.11%)
Metropolis Healthcare
2,030.80
(+1.31%)
Vijaya Diagnostic Centre
1,025.25
(+0.54%)
Thyrocare Technologies
1,356.50
(-1.80%)
Krsnaa Diagnostics
772.80
(-2.19%)
Suraksha Diagnostic
324.05
(+2.30%)
3B BlackBio DX
1,355.90
(-0.67%)
Sastasundar Ventures
298.55
(+1.82%)
Choksi Laboratories
147.70
(-1.47%)